DCGI approves anti Covid-19 drug developed by DRDO for emergency use
NEW DELHI: An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and...
Emergency use
NEW DELHI: An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and...
